💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @TradeWithAlerts | 2 |
| @AlphaAcquirers | 1 |
| @stock_titan | 1 |
| @MarcJacksonLA | 1 |
| @hephaistos_ai | 1 |
Recent Tweets for ALKS
 |
@newsfilterio Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief .. $ALKS… https://t.co/xD2TXRY8b4 1:01am |
 |
@ShortAlgoTrades $ALKS Stock Rating Changed to Hold: Alkermes Plc >> https://t.co/wR7tYokBoY https://t.co/OXejr1HEXT January 25th 2022, 9:01pm |
 |
@AlertTrade DYNAMOgapDOWN $ALKS - Alkermes plc - Ordinary Shares ? TradeIdeas via ? https://t.co/VS8RO1bzXJ January 24th 2022, 4:01pm |
 |
@TradeWithAlerts Nice print for $ALKS Size: 165093 Price: 24.32 Amount: $4,015,061.76 Time: 1600 See more: https://t.co/PB4EeHcDLi J… https://t.co/Arrz6tospX January 20th 2022, 9:01pm |
 |
@bthefirsttoknow First out// $ALKS: The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orp… https://t.co/97dNtJbChX January 20th 2022, 1:01pm |
 |
@1stOncology #Alkermes to Present Data on #NemvaleukinAlfa at the #ASCOGI22 $ALKS https://t.co/nIuKAFEYmu January 19th 2022, 8:01am |
 |
@MarcJacksonLA $ALKS Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Ca… https://t.co/MPcJfrvNNS January 19th 2022, 1:01am |
 |
@AlphaAcquirers $alks looking like it can take off if sustained breakout on 10 min January 18th 2022, 7:01pm |
 |
@Briefingcom $ALKS: Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal... https://t.co/OV5B3qYOxs January 18th 2022, 2:01pm |
 |
@FlashAlert_me $ALKS [15s. delayed]: Issued Press Release on January 18, 07:00:00: Alkermes to Present Data on Nemvaleukin Alfa at… https://t.co/tPUnfFwFyS January 18th 2022, 12:01pm |
 |
@phasefivebot $ALKS Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Ca… https://t.co/XLXserqPDj January 18th 2022, 12:01pm |
 |
@StockNewsBot2 $ALKS Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Ca… https://t.co/BaVZFkmw8g January 18th 2022, 12:01pm |
 |
@hephaistos_ai RT @stock_titan: $ALKS Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Cancers S… January 18th 2022, 12:01pm |
 |
@stock_titan $ALKS Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Ca… https://t.co/vkaXxjYfGA January 18th 2022, 12:01pm |
 |
@otcdynamics $ALKS New National Survey of People Living With Bipolar I Disorder Provides Insights Into Disease-Related Challenge… https://t.co/D0g4r1XVCm January 14th 2022, 4:01pm |
|
@TradeWithAlerts Nice print for $ALKS Size: 371012 Price: 24.87 Amount: $9,227,068.44 Time: 1600 See more: https://t.co/PB4EeHcDLi J… https://t.co/z2jgz2xvzU January 13th 2022, 9:01pm |
 |
@Gambiste1 RT @SnupSnus: Skimming some presentations: Alkermes $ALKS planing to be in the clinic with their Orexin agonist by YE22. Not sure what exa… January 13th 2022, 7:01am |
 |
@SnupSnus Skimming some presentations: Alkermes $ALKS planing to be in the clinic with their Orexin agonist by YE22. Not sur… https://t.co/nxF5Wt9AHl January 13th 2022, 2:01am |
 |
@mediasentiment $ALKS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 881 January 12th 2022, 6:01am |
|
@TradeWithAlerts Nice print for $ALKS Size: 492046 Price: 25.02 Amount: $12,310,990.92 Time: 1600 See more: https://t.co/PB4EeGVAJi… https://t.co/rzQM2Fm9Y2 January 11th 2022, 9:01pm |
 |
@danushman RT @mattdelao: $ALKS Check out this chart I made with @TrendSpider https://t.co/0Gely9wSEM Well ain't that somethin'? January 11th 2022, 8:01pm |
 |
@mattdelao $ALKS Check out this chart I made with @TrendSpider https://t.co/0Gely9wSEM Well ain't that somethin'? January 11th 2022, 8:01pm |
 |
@MC_OptionTrades $ALKS 21-Jan-22 Straddle Implies a ±6.6% move. Jan 12 40th Annual J.P. Morgan Healthcare Conference https://t.co/MVws6KkBgO January 11th 2022, 4:01pm |
 |
@investor_feed $ALKS DEFA14A Alkermes (11 Jan, 7:02am) ? Additional proxy soliciting materials https://t.co/JmKnaLAzwd… https://t.co/NCfoisEzzb January 11th 2022, 12:01pm |
|
@FlashAlert_me $ALKS [15s. delayed] filed form DEFA14A on January 11, 07:02:10 https://t.co/84NwmVj3oU January 11th 2022, 12:01pm |
|
@investor_feed $ALKS 8-K Alkermes (11 Jan, 7:00am) ? Regulation FD Disclosure; Other Events https://t.co/dGGO0wDo6Q #ALKS #8K #Alkermes #News January 11th 2022, 12:01pm |
|
@FlashAlert_me $ALKS [15s. delayed] filed form 8-K on January 11, 07:00:43 https://t.co/1uqrBORjsA January 11th 2022, 12:01pm |
 |
@Market_Newswire $ALKS SEC Filing: 8-K Other Events Reg FD - Alkermes plc. (0001520262) January 11 https://t.co/D0SHiFVmM3 January 11th 2022, 12:01pm |
 |
@Tickeron $ALKS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/NxFnAfwA3Y January 11th 2022, 4:01am |
 |
@InsiderForms $ALKS Sarissa Capital Management LP has filed Form SC 13D/A with SEC. Reporting 8.68% Ownership. Try Insider Forms… https://t.co/MAKvqskTMD January 10th 2022, 9:01pm |
 |
@whalewisdom New SC 13D/A from SARISSA CAPITAL MANAGEMENT LP concerning $ALKS. See details at https://t.co/CjsQUR8dDH January 10th 2022, 9:01pm |
 |
@Jarvis_Alerts $ALKS 29C Exp:21-Jan-22 -- ? Total(Day): $33,644 #UnusualActivity Sign-up free for beta ver.:… https://t.co/joFu0iuzHU January 10th 2022, 1:01pm |
 |
@root_sudosu @WealthBrah @snorlax_uw $ALKS!!! January 9th 2022, 10:01pm |
|
@Tickeron $ALKS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/NIV9KRHJzm January 9th 2022, 3:01am |
 |
@MarketChmln $ALKS option volume was 8X normal on Friday with 3,824 contracts. Call volume was 100% and put volume was 0%. https://t.co/kaOORsmML4 January 8th 2022, 9:01pm |
|
@mattdelao $ALKS Check out this chart I made with @TrendSpider https://t.co/4BtE5bGlg9 AVWAP tag incoming? January 8th 2022, 4:01pm |
 |
@Rogoletsgo @Crowd_Traders i think i found some #uoa in $ALKS 01/21 $29 call has a volume of 3255 and 0/oi? never seen that be… https://t.co/gAxscBvi6Q January 8th 2022, 3:01pm |
 |
@PaulTorresCohen Paul Torres-Cohen $ALKS January 8th 2022, 1:01pm |
 |
@usasingh1 @Tomikazi1 These can be worth 1000% if stock hits 35 bucks in 2 weeks . $ALKS. #1 Top holding of Sarisaa Capital January 8th 2022, 4:01am |
 |
@FinancialAdvBot Hold $ALKS! https://t.co/LRTelXM9r3 January 8th 2022, 4:01am |
|
@usasingh1 There has to be something in next 2 weeks $ALKS . #1 Holding for Alexander Denner. Thats the key along with $IRWD .let s see @BigCForever January 8th 2022, 4:01am |
|
@usasingh1 $ALKS 41000 Volume after hours . Any news next week ? Hope for good news .some volume in Jan 29 calls .Similar acti… https://t.co/wUCagH3hqg January 8th 2022, 2:01am |
 |
@Tomikazi1 Those Cheeky Bastards snuck this in in the last 10 seconds of the day. $ALKS https://t.co/gCiqfSKgHy January 8th 2022, 12:01am |
|
@Jarvis_Alerts $ALKS 29C Exp:21-Jan-22 -- ? Total(Day): $33,644 #UnusualActivity Sign-up free for beta ver.:… https://t.co/0Lj6RYcrRH January 7th 2022, 10:01pm |
 |
@SptAdd Average $ALKS call volume 126, today so far: 2,600+. Most of the volume is for Jan expiration https://t.co/MJq5dYyDUF January 7th 2022, 7:01pm |
|
@SnupSnus @PropThinker Interesting analysis, and another IL-2 company? ( $ALKS also playing I this space), not sure more IL-2… https://t.co/6FK92vUPpT January 7th 2022, 6:01pm |
|
@SptAdd Started $ALKS - replacing clinical companies with revenue generating ones January 7th 2022, 3:01pm |
|
@phasefivebot $ALKS New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenge… https://t.co/DPptMA5Qmg January 6th 2022, 12:01pm |
|
@1stOncology #Alkermes to Take Part in the 40th Annual J.P. Morgan #HealthcareConference $ALKS https://t.co/GBTAyLAUJ1 January 6th 2022, 10:01am |
|
@newsfilterio Alkermes to Take Part in the 40th Annual J.P. Morgan Healthcare Conference $ALKS https://t.co/fmWW5DW5WD January 6th 2022, 1:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?